Comparison of exhaled nitric oxide measurements between NIOX MINO® electrochemical and Ecomedics chemiluminescence analyzer von Boot, J.D, de Ridder, L, de Kam, M.L, Calderon, C, Mascelli, M.A, Diamant, Z

Volltext

Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease von Belkowski, S. M., Boot, J. D., Mascelli, M. A., Diamant, Z., De Garavilla, L., Hertzog, B., Polkovitch, D., Towers, M., Batheja, A., D'Andrea, M. R.

Volltext

Analysis of GPIIb/IIIa Receptor Number by Quantification of 7E3 Binding to Human Platelets von Wagner, Carrie L., Mascelli, Mary A., Neblock, Donald S., Weisman, Harlan F., Coller, Barry S., Jordan, Robert E.

Volltext

Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis von Boot, J.D, de Kam, M.L, Mascelli, M.A, Miller, B, van Wijk, R. Gerth, de Groot, H, Cohen, A.F, Diamant, Z

Volltext

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade von MASCELLI, M. A, LANCE, E. T, DAMARAJU, L, WAGNER, C. L, WEISMAN, H. F, JORDAN, R. E, PHD

Volltext

Comparison of biomarkers between allergic rhinitis only and allergic rhinitis with concomitant asthma von Wang, W.Y, Boot, J.D, Mascelli, M.A, Gerth van Wijk, R, Diamant, Z

Volltext

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy von Sane, David C, Damaraju, Lakshmi V, Topol, Eric J, Cabot, Catherine F, Mascelli, Mary Ann, Harrington, Robert A, Simoons, Maarten L, Califf, Robert M

Volltext

Ig H and L chain contributions to autoimmune specificities von Radic, MZ, Mascelli, MA, Erikson, J, Shan, H, Weigert, M

Volltext

GPIIb-IIIa Antagonist-induced Reduction in Platelet Surface Factor V/Va Binding and Phosphatidylserine Expression in Whole Blood von Furman, Mark I., Krueger, Lori A., Frelinger, A. L., Barnard, Marc R., Mascelli, Mary Ann, Nakada, Marian T., Michelson, Alan D.

Volltext

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy von MASCELLI, M. A, WORLEY, S, VERIABO, N. J, LANCE, E. T, MACK, S, SCHAIBLE, T, WEISMAN, H. F, JORDAN, R. E

Volltext

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thr... von COULTER, S. A, CANNON, C. P, BARNATHAN, E. S, BRAUNWALD, E, KLEIMAN, N. S, AULT, K. A, ANTMAN, E. M, DE WERF, F. V, ADGEY, A. A. J, GIBSON, C. M, GIUGLIANO, R. P, MASCELLI, M. A, SCHERER, J

Volltext

In Vitro Dose Response to Different GPIIb/IIIa-Antagonists: Inter-Laboratory Comparison of Various Platelet Function Tests von Harder, S, Klinkhardt, U, Graff, J, Westrup, D, Kirchmaier, C.M, Glusa, E, Mascelli, M.A, Marciniak, S.J, Just, A, Lösche, W, Breddin, H.K

Volltext

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization von LINCOFF, A. Michael, KEREIAKES, Dean J, MASCELLI, Mary A, DECKELBAUM, Lawrence I, BARNATHAN, Elliot S, PATEL, Kamlesh K, FREDERICK, Bart, NAKADA, Marian T, TOPOL, Eric J

Volltext

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists von Michelson, A D, Furman, M I, Goldschmidt-Clermont, P, Mascelli, M A, Hendrix, C, Coleman, L, Hamlington, J, Barnard, M R, Kickler, T, Christie, D J, Kundu, S, Bray, P F

Volltext

Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty von FREDRICKSON, B. J, TURNER, N. A, KLEIMAN, N. S, GRAZIADEI, N, MARESH, K, MASCELLI, M. A, EFFRON, M. B, MCINTIRE, L. V

Volltext

Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab von Mascelli, Mary A., Kleiman, Neal S., Marciniak, Stanley J., Damaraju, Lakshmi, Weisman, Harlan F., Jordan, Robert E.

Volltext

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes von WILLIAMS, R. Taylor, DAMARAJU, Lakshmi V, MASCELLI, Mary Ann, BARNATHAN, Elliot S, CALIFF, Robert M, SIMOONS, Maarten L, DELIARGYRIS, Efthymios N, SANE, David C

Volltext

Abciximab readministration: Results of the reopro readministration registry von TCHENG, James E, KEREIAKES, Dean J, DAMARAJU, Lakshmi, SCHANTZ, Allen, EFFRON, Mark B, BRADEN, Gregory A, LINCOFF, A. Michael, GEORGE, Barry S, KLEIMAN, Neal S, SANE, David C, CINES, Douglas B, JORDAN, Robert E, MASCELLI, Mary Ann, LANGRALL, Mary Ann

Volltext

Readministration of abciximab: Interim report of the ReoPro Readministration Registry von Tcheng, James E., Kereiakes, Dean J., Braden, Gregory A., Jordan, Robert E., Mascelli, Mary Ann, Langrall, Mary Ann, Effron, Mark B.

Volltext

Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: Ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions von Kleiman, Neal S., Grazeiadei, Nikki, Maresh, Kelly, Taylor, Rebecca J., Frederick, Bart, Lance, Ellen T., Effron, Mark B., Jordan, Robert E., Mascelli, Mary A.

Volltext